Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study
Drugs & Aging · 2026-11 · 43 (11) · 1001-1010
DOI: 10.1007/s40266-026-01337-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drugs & Aging, online erschienen am 28.09.2026. Verfasst von Yinfang Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Nanfang Hospital, National Clinical Research Center for Kidney and Urological Diseases, State Key Laboratory of Multi-organ I…. Hauptthemen laut MEDLINE: Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Calcium Channel Blockers. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Key R&D Program of China.
Themen: Demenz
Abstract (Originalsprache)
OBJECTIVE: The aim of this study was to evaluate whether renin-angiotensin system inhibitors (RASIs) reduce dementia risk independently of blood pressure control compared with calcium channel blockers (CCBs) in antihypertensive-naïve adults with hypertension. METHODS: This multicenter, new-user active comparator study included antihypertensive-naïve adults initiating RASIs or CCBs across 28 hospitals. Participants were matched 1:1 on baseline characteristics using propensity score matching (PSM). The primary outcome was incident all-cause dementia; secondary outcomes were Alzheimer's disease and vascular dementia. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards regression. RESULTS: Of 164,918 eligible patients (median age 65 years [interquartile range 55-74]; 51.2% male), 54,042 PSM pairs initiating RASIs versus CCBs were included. During a median follow-up of 516 days, 344 incident dementia cases occurred. The incidence rate of all-cause dementia was lower among RASI initiators than CCB initiators (1.26 vs 1.89 per 1000 person-years). Initiation of RASIs was associated with a significantly lower risk of all-cause dementia (HR 0.68, 95% CI 0.55-0.84) and Alzheimer's disease (HR 0.59, 95% CI 0.43-0.81), but not vascular dementia (HR 0.74, 95% CI 0.50-1.11), compared with CCBs. There was no significant difference in dementia risk between initiators of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). CONCLUSIONS: In adults with hypertension, initiation of RASIs was associated with a significantly lower risk of dementia compared with CCBs. No significant difference was observed between ACEIs and ARBs. Further validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Nanfang Hospital, National Clinical Research Center for Kidney and Urological Diseases, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Provincial Key Laboratory of…
- The First Clinical College, Dalian Medical University, Liaoning, China.
- Nanfang Hospital, Southern Medical University, Guangzhou, China. mr_whouse@163.com.
Förderung
- National Key R&D Program of China
Zitieren
APA
Sun, Y., Guo, Z., Zhang, J., Pang, M., Chen, R., She, C., Zhou, S., Wang, H., Shao, X., & Nie, S. (2026). Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study. Drugs & Aging, 43(11), 1001-1010. https://doi.org/10.1007/s40266-026-01337-2
Vancouver
Sun Y, Guo Z, Zhang J, Pang M, Chen R, She C, et al. Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study. Drugs & Aging. 2026;43(11):1001-1010. doi:10.1007/s40266-026-01337-2
BibTeX
@article{Sun2026,
author = {Sun, Yinfang and Guo, Zhixin and Zhang, Jinming and Pang, Mingzhen and Chen, Ruixuan and She, Caoxiang and Zhou, Shiyu and Wang, Hao and Shao, Xian and Nie, Sheng},
title = {Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study},
journal = {Drugs & Aging},
year = {2026},
volume = {43},
number = {11},
pages = {1001--1010},
doi = {10.1007/s40266-026-01337-2}
}
EUVIMED